Manufacturer record
Ravenbhel Healthcare Pvt. Ltd. 16-17: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Ravenbhel Healthcare Pvt. Ltd. 16-17 (Jammu & Kashmir) were declared Not of Standard Quality between April 2020 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Ravenbhel Healthcare Pvt. Ltd. 16-17 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Albendazole Tablets IP 400mg | 296725043Mfg 2025-04 · Exp 2027-03 | The sample does not conform to IP 2022 requirements w.r.t Dissolution TestDissolution | DTL,Dalgate Srinagar kashmirState lab | Apr 2026 |
| Exudase DP | 3023118Mfg 2023-09 · Exp 2025-08 | The sample fails in the test, ?Description of tablets?.Description | State Drugs Testing Laboratory Srinagar (Jammu & Kashmir)State lab | Apr 2024 |
| CDPIN 10 (Cilnidipine Tablets I.P. 10 mg) | 549J001Mfg 2019-10 · Exp 2021-03 | AssayAssay | CDL KolkataCDSCO lab | Apr 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.